Literature DB >> 8142124

Acute and delayed effects of radiotherapy in patients with oesophageal squamous cell carcinoma treated with chemotherapy, surgery and pre- and postoperative radiotherapy.

M Cwikiel1, M Albertsson, G Hambraeus.   

Abstract

Among 73 patients with oesophageal squamous cell carcinoma treated with chemotherapy (cisplatin + 5-fluorouracil), surgery and pre- and postoperative radiotherapy, the 1-year survival rate was 68% and the 5-year rate 26%. The treatment was well tolerated, though there were 11 cases of pericardial or pleural effusion, in all of which the effusion was benign and could be successfully treated with pleural aspiration and/or pleurodesis, pericardiocentesis, or in one case pericardectomy.

Entities:  

Mesh:

Year:  1994        PMID: 8142124     DOI: 10.3109/02841869409098375

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  4 in total

1.  Promise of definitive chemoradiotherapy for esophageal cancer balanced with late radiation toxicity: an old but new issue.

Authors:  Ichinosuke Hyodo
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

Review 2.  Constrictive Pericarditis 5 Months after Radiation Therapy in a 62-Year-Old Woman with Esophageal Cancer.

Authors:  Beeletsega T Yeneneh; Sorcha Allen; Prasad Panse; Farouk Mookadam; William Rule
Journal:  Tex Heart Inst J       Date:  2017-12-19

Review 3.  Cardiovascular sequelae of radiation therapy.

Authors:  Francesco Santoro; Nicola Tarantino; Pier Luigi Pellegrino; Marica Caivano; Agostino Lopizzo; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Clin Res Cardiol       Date:  2014-05-07       Impact factor: 5.460

4.  Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer.

Authors:  Yaqin Zhao; Lu Chen; Shu Zhang; Qiang Wu; Xiaoqin Jiang; Hong Zhu; Jin Wang; Zhiping Li; Yong Xu; Ying Jie Zhang; Sen Bai; Feng Xu
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.